[Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
D000368:Aged; D000481:Allantoin / Q000652:urine; D000937:Antigen-Antibody Reactions; D003168:Complement Fixation Tests; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007114:Immunization; D008297:Male; D010088:Oxidoreductases / Q000008:administration & dosage; D011687:Purines / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D014503:Urate Oxidase / Q000627:therapeutic use*; D014527:Uric Acid / Q000096:biosynthesis / Q000097:blood* / Q000378:metabolism / Q000652:urine*; D014969:Xanthine Oxidase / Q000378:metabolism; D014970:Xanthines / Q000652:urine
D011687:Purines; D014970:Xanthines; D014527:Uric Acid; D000481:Allantoin; D010088:Oxidoreductases; D014969:Xanthine Oxidase; D014503:Urate Oxidase
Modalités d'élimination des purines au cours du traitement enzymatique de la goutte et des états hyper-uricémiques par une urate-oxydase.